BAY2395840
Sponsors
Bayer
Conditions
Diabetes MellitusDiabetic Neuropathic PainHealthy VolunteersNeuropathic Pain Associated With Diabetic Peripheral NeuropathyPeripheral Neuropathic PainRenal Impairment
Phase 1
A Study to Learn How the Study Treatment BAY2395840 Moves Into, Through and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Moderate Reduced Kidney Function and in Healthy Male and Female Participants With Normal Kidney Function
WithdrawnNCT05406219
Start: 2023-05-15End: 2023-10-12Updated: 2023-04-19
A Study to Learn How Safe the Study Treatment BAY2395840 is, How it Affects the Body and How it Moves Into, Through, and Out of the Body if Given in Single and in Repetitive Doses to Japanese Healthy Male Participants
CompletedNCT05563454
Start: 2022-10-11End: 2023-02-28Updated: 2023-03-15